Guidance

MMR: patient group direction (PGD) template

PGD template to support the national MMR vaccination programme.

Applies to England

Documents

MMR: patient group direction (PGD) template

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of measles, mumps and rubella (MMR) vaccine, to individuals born on or before 31 December 2019 requiring opportunistic catch up for routine immunisation, or for travel to endemic areas or measles outbreak management.

The MMR PGD may be used by those 6 to 12 months of age at time of presentation if early MMR protection is required, such as for travel or measles outbreak.

MMR vaccine PGD version 7.0 is valid from 1 January 2026 to 30 November 2028.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy and procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Updates to this page

Published 24 March 2016
Last updated 22 December 2025 show all updates
  1. Added version 7.0, see page 3 for change history.

  2. Added version 6.0, see page 2 for change history.

  3. Added version 5, see page 2 for change history.

  4. Added version 4 (see page 2 for change history).

  5. Added V03.00 - routine review.

  6. Routine PGD update on expiry of v01.00.

  7. First published.

Sign up for emails or print this page